Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Dexcom (DXCM) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Dexcom (DXCM) over the last 16 years, with Q4 2025 value amounting to $39.5 million.

  • Dexcom's Accumulated Depreciation & Amortization fell 100.25% to $39.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $39.5 million, marking a year-over-year decrease of 100.25%. This contributed to the annual value of $39.5 million for FY2025, which is 100.25% down from last year.
  • Per Dexcom's latest filing, its Accumulated Depreciation & Amortization stood at $39.5 million for Q4 2025, which was down 100.25% from $9.6 million recorded in Q3 2025.
  • Over the past 5 years, Dexcom's Accumulated Depreciation & Amortization peaked at $466.3 million during Q3 2023, and registered a low of $9.2 million during Q1 2025.
  • In the last 5 years, Dexcom's Accumulated Depreciation & Amortization had a median value of $40.8 million in 2023 and averaged $81.8 million.
  • As far as peak fluctuations go, Dexcom's Accumulated Depreciation & Amortization skyrocketed by 43271.14% in 2023, and later tumbled by 9796.27% in 2024.
  • Over the past 5 years, Dexcom's Accumulated Depreciation & Amortization (Quarter) stood at $102.0 million in 2021, then tumbled by 54.22% to $46.7 million in 2022, then fell by 10.28% to $41.9 million in 2023, then fell by 4.77% to $39.9 million in 2024, then dropped by 1.0% to $39.5 million in 2025.
  • Its Accumulated Depreciation & Amortization was $39.5 million in Q4 2025, compared to $9.6 million in Q3 2025 and $9.3 million in Q2 2025.